LONDON–(BUSINESS WIRE)–#GlobalRealWorldEvidenceSolutionsMarket–Technavio has been monitoring the real-world evidence solutions market and it is poised to grow by USD 697.92 million during 2020-2024, progressing at a CAGR of almost 13% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavio’s in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. Download a Free Sample Report on COVID-19 Impacts

Frequently Asked Questions-

• What was the size of the real-world evidence solutions market in 2019?
• Technavio says that the value of the market was at USD 834.28 million in 2019 and is projected to reach USD 1,532.20 million by 2024.

• At what rate is the market projected to grow?
• Growing at a CAGR of almost 13%, the incremental growth of the market is anticipated to be USD 697.92 million during the forecast period.

(Read more…)

• Who are the top players in the market?
• Clinigen Group Plc, ICON Plc, International Business Machines Corp., IQVIA Inc., Laboratory Corp. of America Holdings, Parexel International Corp., PerkinElmer Inc., Pharmaceutical Product Development LLC, SAS Institute Inc., and Syneos Health Inc. are some of the major market participants.

• What are the key market drivers and challenges?
• The benefits of real-world evidence solutions and the integration of EHRs with electronic data collection systems are the major factors driving the market. However, the lack of standardized frameworks for real-world evidence solutions restraints the market growth.

• How big is the Americas market?
• The market in the Americas region was valued at USD 415.13 million in 2019 and it is anticipated to grow to USD 780.51 million by 2024.

The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Clinigen Group Plc, ICON Plc, International Business Machines Corp., IQVIA Inc., Laboratory Corp. of America Holdings, Parexel International Corp., PerkinElmer Inc., Pharmaceutical Product Development LLC, SAS Institute Inc., and Syneos Health Inc. are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

The benefits of real-world evidence solutions have been instrumental in driving the growth of the market.

Technavio’s custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations.

Real-World Evidence Solutions Market 2020-2024: Segmentation

Real-World Evidence Solutions Market is segmented as below:

• Therapeutic Area
  • Oncology
  • Immunology
  • Cardiology
  • Neurology
  • Others
• Geography
  • Americas
  • EMEA
  • APAC

To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR41122

Real-World Evidence Solutions Market 2020-2024: Scope

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The real-world evidence solutions market report covers the following areas:

• Real-World Evidence Solutions Market Size
• Real-World Evidence Solutions Market Trends
• Real-World Evidence Solutions Market Analysis

This study identifies the integration of EHRs with electronic data collection systems as one of the prime reasons driving the real-world evidence solutions market growth during the next few years.

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.

Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio’s SUBSCRIPTION platform

Real-World Evidence Solutions Market 2020-2024: Key Highlights

• CAGR of the market during the forecast period 2020-2024
• Detailed information on factors that will assist real-world evidence solutions market growth during the next five years
• Estimation of the real-world evidence solutions market size and its contribution to the parent market
• Predictions on upcoming trends and changes in consumer behavior
• The growth of the real-world evidence solutions market
• Analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of real-world evidence solutions market vendors

Table of Contents:

Executive Summary

Market Landscape

• Market ecosystem
• Value chain analysis

Market Sizing

• Market definition
• Market segment analysis
• Market size 2019
• Market outlook: Forecast for 2019-2024

Five Forces Analysis

• Five Forces Summary
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

Market Segmentation by therapeutic area

• Market segments
• Comparison by therapeutic area
• Oncology – Market size and forecast 2019-2024
• Immunology – Market size and forecast 2019-2024
• Cardiology – Market size and forecast 2019-2024
• Neurology – Market size and forecast 2019-2024
• Others – Market size and forecast 2019-2024
• Market opportunity by therapeutic area

Customer Landscape

Geographic Landscape

• Geographic segmentation
• Geographic comparison
• Americas – Market size and forecast 2019-2024
• EMEA – Market size and forecast 2019-2024
• APAC – Market size and forecast 2019-2024
• Key leading countries
• Market opportunity by geography

Volume Driver – Demand led growth

Market Challenges

Market Trends

Vendor Landscape

• Overview
• Vendor landscape
• Landscape disruption

Vendor Analysis

• Vendors covered
• Market positioning of vendors
• Clinigen Group Plc
• ICON Plc
• International Business Machines Corp.
• IQVIA Inc.
• Laboratory Corp. of America Holdings
• Parexel International Corp.
• PerkinElmer Inc.
• Pharmaceutical Product Development LLC
• SAS Institute Inc.
• Syneos Health Inc.

Appendix

• Scope of the report
• Currency conversion rates for US$
• Research methodology
• List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email: [email protected]
Website: www.technavio.com/

LONDON–(BUSINESS WIRE)–#GlobalRealWorldEvidenceSolutionsMarket–Technavio has been monitoring the real-world evidence solutions market and it is poised to grow by USD 697.92 million during 2020-2024, progressing at a CAGR of almost 13% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavio’s in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. Download a Free Sample Report on COVID-19 Impacts

Frequently Asked Questions-

• What was the size of the real-world evidence solutions market in 2019?
• Technavio says that the value of the market was at USD 834.28 million in 2019 and is projected to reach USD 1,532.20 million by 2024.

• At what rate is the market projected to grow?
• Growing at a CAGR of almost 13%, the incremental growth of the market is anticipated to be USD 697.92 million during the forecast period.

(Read more…)

• Who are the top players in the market?
• Clinigen Group Plc, ICON Plc, International Business Machines Corp., IQVIA Inc., Laboratory Corp. of America Holdings, Parexel International Corp., PerkinElmer Inc., Pharmaceutical Product Development LLC, SAS Institute Inc., and Syneos Health Inc. are some of the major market participants.

• What are the key market drivers and challenges?
• The benefits of real-world evidence solutions and the integration of EHRs with electronic data collection systems are the major factors driving the market. However, the lack of standardized frameworks for real-world evidence solutions restraints the market growth.

• How big is the Americas market?
• The market in the Americas region was valued at USD 415.13 million in 2019 and it is anticipated to grow to USD 780.51 million by 2024.

The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Clinigen Group Plc, ICON Plc, International Business Machines Corp., IQVIA Inc., Laboratory Corp. of America Holdings, Parexel International Corp., PerkinElmer Inc., Pharmaceutical Product Development LLC, SAS Institute Inc., and Syneos Health Inc. are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

The benefits of real-world evidence solutions have been instrumental in driving the growth of the market.

Technavio’s custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations.

Real-World Evidence Solutions Market 2020-2024: Segmentation

Real-World Evidence Solutions Market is segmented as below:

• Therapeutic Area
  • Oncology
  • Immunology
  • Cardiology
  • Neurology
  • Others
• Geography
  • Americas
  • EMEA
  • APAC

To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR41122

Real-World Evidence Solutions Market 2020-2024: Scope

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The real-world evidence solutions market report covers the following areas:

• Real-World Evidence Solutions Market Size
• Real-World Evidence Solutions Market Trends
• Real-World Evidence Solutions Market Analysis

This study identifies the integration of EHRs with electronic data collection systems as one of the prime reasons driving the real-world evidence solutions market growth during the next few years.

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.

Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio’s SUBSCRIPTION platform

Real-World Evidence Solutions Market 2020-2024: Key Highlights

• CAGR of the market during the forecast period 2020-2024
• Detailed information on factors that will assist real-world evidence solutions market growth during the next five years
• Estimation of the real-world evidence solutions market size and its contribution to the parent market
• Predictions on upcoming trends and changes in consumer behavior
• The growth of the real-world evidence solutions market
• Analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of real-world evidence solutions market vendors

Table of Contents:

Executive Summary

Market Landscape

• Market ecosystem
• Value chain analysis

Market Sizing

• Market definition
• Market segment analysis
• Market size 2019
• Market outlook: Forecast for 2019-2024

Five Forces Analysis

• Five Forces Summary
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

Market Segmentation by therapeutic area

• Market segments
• Comparison by therapeutic area
• Oncology – Market size and forecast 2019-2024
• Immunology – Market size and forecast 2019-2024
• Cardiology – Market size and forecast 2019-2024
• Neurology – Market size and forecast 2019-2024
• Others – Market size and forecast 2019-2024
• Market opportunity by therapeutic area

Customer Landscape

Geographic Landscape

• Geographic segmentation
• Geographic comparison
• Americas – Market size and forecast 2019-2024
• EMEA – Market size and forecast 2019-2024
• APAC – Market size and forecast 2019-2024
• Key leading countries
• Market opportunity by geography

Volume Driver – Demand led growth

Market Challenges

Market Trends

Vendor Landscape

• Overview
• Vendor landscape
• Landscape disruption

Vendor Analysis

• Vendors covered
• Market positioning of vendors
• Clinigen Group Plc
• ICON Plc
• International Business Machines Corp.
• IQVIA Inc.
• Laboratory Corp. of America Holdings
• Parexel International Corp.
• PerkinElmer Inc.
• Pharmaceutical Product Development LLC
• SAS Institute Inc.
• Syneos Health Inc.

Appendix

• Scope of the report
• Currency conversion rates for US$
• Research methodology
• List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email: [email protected]
Website: www.technavio.com/